Outcome of Board Meeting

August 08, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: MEDIASSIST Scrip Code: 544088 Dear Sir/ Madam, Subject: Unaudited Financial Results for the quarter ended June 30, 2026 Reference: Regulations 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 The Board of Directors of Medi Assist Healthcare Services Limited (the “Company”) at their meeting held today i.e., August 08, 2026, have inter-alia, approved the unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. Copy of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 along with Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith. The Board Meeting commenced at 1.45 p.m. (IST) and concluded at 3.00 p.m. (IST). This intimation shall also be made available on the Company’s website at www.mediassist.in. You are requested to take the same on record. Yours faithfully, For Medi Assist Healthcare Services Limited Rashmi B V Company Secretary & Compliance Officer ICSI Membership No: A38729 Encl.: As above . SV Tower, No. 27, Floor 4 M S K A & ASSOC]ateS LLP 80 Feet Road, 6th Block, Koramangala (Formerly known as M S K A & Associates) ARSI 6000 MDA Chartered Accountants Independent Auditor’s Review Report on standalone unaudited financial results of Medi Assist Healthcare Services Limited for the quarter pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Medi Assist Healthcare Services Limited (hereinafter referred to as ‘the Company’) for the quarter ended June 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Company’s Management and has been approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Page 1 of 2 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | HKochi | Kolkata | Mumbai | Pune www.mska.in MSKA & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants 5. Emphasis of matter We draw attention to Note 7 to the accompanying Statement which describes that search and seizure operation was carried out by the Directorate of Enforcement at certain offices of a wholly owned subsidiary and the management's assessment thereof about the consequent impact on the Statement. Our conclusion is not modified in respect of this matter. For M S K A & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants ICAI Firm Registration No.105047W/W101187 Pankaj S Bhauwala Partner Membership No.: 233552 UDIN: 26233552IKWBNS5773 Place: Bengaluru Date: August 08, 2026 Page 2 of 2 s Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | Kochi | Kolkata | Mumbai | Pune www.mska.in Medi Assist Healthcare Services Limited Corporate Identity Number; L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road. Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: ask@mediassist.in: website: www.mediassist.in Statement of unaudited standalone financial results for the quarter ended 30 June 2026 (Rs. in millions unless otherwise stated) Quarter ended Year ended Sr. No. Particulars 30 June 2026 31 March 2026 30 June 2025 31 March 2026 Unaudited Audited Unaudited Audited (refer note 3) (refer note 4) 1 Income Revenue from operations 589.84 635.63 437.04 2.254.55 Other income 70.28 51.48 2361 146.31 Total income 660.12 687.11 460.65 2,400.86 2 Expenses Employee benefits expense 132.00 119.10 69.59 426.20 Finance costs 11.12 4577 8.69 65.26 Depreciation and amortisation expenses 48.81 51.32 50.69 203.22 Other expenses 291.20 276.93 223.15 1.018.00 Total expenses 483.13 493.12 352.12 1,712.68 3 Profit before exceptional item and tax (1-2) 176.99 193.99 108.53 688.18 4 Exceptional item (refer note 10) - - = 0.52 5 Profit before tax for the period/ year (3-4) 176.99 193.99 108.53 687.66 6 Income tax expense: Current tax 31.78 56.76 26.24 187.88 Deferred tax expense /(credit) 13.69 (7.74) 2.09 (20.08) Total income tax expense 45.47 49.02 28.33 167.80 7 Profit for the period/ year (5-6) 131.52 144,97 80.20 519.86 8 Other comprehensive income/(loss) Items that will not be reclassified subsequently to statement of prolilb and loss Re-measurement of gains/(losses) on defined benefit plans (1.18) (2.45) 0.07 1.45 !:aar value changes in equity instruments through other comprehensive 637 4.78) 474 (4.61) income Income tax relating to items that will not be reclassified to statement of profit 0.68 i ©.71) ©.71) and loss Total other comprehensive income/(loss) for the period/ year, net of tax 5.87 (7.23) 4.10 (3.87) 9 Total comprehensive income for the period/ year (7+8) 137.39 137.74 84.30 515.99 10 Paid up equity share capital (face value of Rs. 5 each) 373.51 373.05 352.69 373.05 11 Other equity 4,520.83 12 Earnings per equity share (face value of Rs. 5 each) (not annualised except for the year ended 31 March 2026) Basic (Rs) 1.76 1.95 1.14 7.18 Diluted (Rs) 1.76 1.95 1.13 7.18 (Page 1 of 3) Notes to statement of unaudited standalone financial results for the quarter ended 30 June 2026 In terms of Regul [Showing first 8,000 characters — download PDF for full document]